The following acts and the causing thereof are hereby prohibited:
(1) The sale in intrastate commerce of any drug, device, or cosmetic that is adulterated or misbranded.(2) The adulteration or misbranding of any drug, device, or cosmetic in intrastate commerce.(3) The receipt in intrastate commerce of any drug, device, or cosmetic that is adulterated or misbranded, and the sale thereof in such commerce for pay or otherwise.(4) The introduction or delivery for introduction into intrastate commerce of any new drug in violation of RCW 69.04.570.(5) The dissemination within this state, in any manner or by any means or through any medium, of any false advertisement.(6) The refusal to permit (a) entry and the taking of a sample or specimen or the making of any investigation or examination as authorized by RCW 69.04.780; or (b) access to or copying of any record as authorized by RCW 69.04.810.(7) The refusal to permit entry or inspection as authorized by RCW 69.04.820.(8) The removal, mutilation, or violation of an embargo notice as authorized by RCW 69.04.110.(9) The giving of a guaranty or undertaking in intrastate commerce, referred to in RCW 69.04.080, that is false.(10) The alteration, mutilation, destruction, obliteration, or removal of the whole or any part of the labeling of a drug, device, or cosmetic, or the doing of any other act with respect to a drug, device, or cosmetic, or the labeling or advertisement thereof, which results in a violation of this chapter.(11) The using in intrastate commerce, in the labeling or advertisement of any drug, of any representation or suggestion that an application with respect to such drug is effective under section 505 of the federal act or under RCW 69.04.570, or that such drug complies with the provisions of either such section.Amended by 2018 c 236,§ 601, eff. 6/7/2018.1945 c 257 § 22; Rem. Supp. 1945 § 6163-71. Prior: 1917 c 168 § 1; 1907 c 211 § 1; 1901 c 94 § 1.